BNP Paribas Financial Markets
AVEO

BNP Paribas Financial Markets’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

BNP Paribas Financial Markets’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,985
Closed -$49.3K – 5014
2022
Q3 		$49.3K Buy
+5,985
New +$46K ﹤0.01% 3986
2020
Q1 		– Sell
-4
Closed -$27 – 4546
2019
Q4 		$27 Sell
4
-1,188
-100% -$8.75K ﹤0.01% 4372
2019
Q3 		$10.1K Sell
1,192
-57
-5% -$424 ﹤0.01% 4150
2019
Q2 		$8.41K Sell
1,249
-1,469
-54% -$12.6K ﹤0.01% 4139
2019
Q1 		$22.3K Buy
2,718
+2,592
+2,057% +$26.8K ﹤0.01% 3874
2018
Q4 		$2.01K Sell
126
-206
-62% -$4.53K ﹤0.01% 3799
2018
Q3 		$11K Sell
332
-2
-0.6% -$51 ﹤0.01% 3682
2018
Q2 		$7.54K Buy
+334
New +$7.92K ﹤0.01% 3914
2014
Q3 		– Sell
-88
Closed -$1.6K – 4363
2014
Q2 		$1.6K Buy
88
+14
+19% +$182 ﹤0.01% 3222
2014
Q1 		$914 Sell
74
-48
-39% -$862 ﹤0.01% 2889
2013
Q4 		$2.25K Sell
122
-1,390
-92% -$27.8K ﹤0.01% 3605
2013
Q3 		$31.1K Sell
1,512
-406
-21% -$9.3K ﹤0.01% 2551
2013
Q2 		$48K Buy
+1,918
New +$82K ﹤0.01% 2673

Other funds holding AVEO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

BNP Paribas Financial Markets's AVEO Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 5,985 shares — an estimated $49.3K sold.

BNP Paribas Financial Markets first reported a position in AVEO in Q2 2013 and held it in 13 quarters. The position peaked at $49.3K in Q3 2022. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 5,985 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $49.3K.
  • BNP Paribas Financial Markets first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
  • BNP Paribas Financial Markets's AVEO Pharmaceuticals, Inc. position peaked at $49.3K in Q3 2022.
  • 110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.